Single-use Bioprocessing Market - Databook 2025 to 2034

The global single-use bioprocessing market size surpassed USD 32,540 million in 2024 and is predicted to reach around USD 1,47,300 million by 2034, registering a CAGR of 16.3% from 2025 to 2034.

Highlights of the Single-use Bioprocessing Market

• North America dominated the global single-use bioprocessing market in 2024.
• Europe is expected to show the fastest growth in the forecasted period of 2025-2034.
• By product, simple & peripheral elements and apparatus & plants dominated the single-use bioprocessing market in 2024.
• By product, work equipment like cell culture systems and syringes are projected to grow rapidly in the forecasted period.
• By workflow, upstream bioprocessing contributed to the most market share in 2024.
• By workflow, fermentation and downstream bioprocessing are expected to have the fastest growth.
• By end-use, biopharmaceutical manufacturers dominated the market in 2024.
• By end-use, academic and clinical research institutes are projected to show the fastest growth during the forecasted period of 2025-2034.

Industry Valuation and Growth Rate Projection

Bioprocessing is the process of manufacturing products using living organisms, cells, or their components. Single-use bioprocessing equipment includes utilizing disposable equipment and materials for biopharmaceutical manufacturing. Disposable equipment and materials eliminate the risk of contamination, lower production costs, increase scalability, and provide faster turnaround time as compared to other traditional reusable systems. The rise in chronic disease also adds to the market drivers for the market.

The single-use bioprocessing market consists of a high level of merger & acquisition (M&A) activities by the leading companies to increase their research and development on the market and increase production for such bioprocessing equipment. With the increase in investment by the government and many private institutions, the market strives to expand rapidly.

Single-use Bioprocessing Market: Stats and Figures

• The post-pandemic era has significantly increased the demand for biologics, resulting in more product approvals. In 2023, the U.S. FDA approved 17 biologics out of a total of 55 new drugs.
• More than 80% of the biopharmaceutical plants have adopted single-use bioprocessing systems as it is cheaper, efficient, and reliable.
• The people of America are dealing with multiple chronic conditions; 42% have two or more, and 12% have at least 5.

How AI Has Benefitted the Single-use Bioprocessing Market

• Artificial Intelligence (AI) brings a major impact in the single-use bioprocessing market by improving operational efficiency and ensuring high-grade standards integration in the production process.
• AI also helps in streamlining the business and its functions for greater efficiency whilst decreasing human error and enhancing the overall traceability of the production.
• AI helps in reducing the cost of production for businesses in the single-use bioprocessing market through automation and data analysis, and predictive modelling.

Industry Leader Announcements

• Kim Kelderman, Bio-Techne's President/and Chief Executive Officer

"We are excited to partner with Thermo Fisher to expand the reach of our products and services throughout Europe, by leveraging the Fisher Scientific Channel's extensive European distribution network and industry expertise, we aim to enhance support for researchers and accelerate scientific discoveries that address some of the most pressing challenges in healthcare today."

• Joachim Kreuzburg, CEO of Sartorius.

“MatTek’s solutions add to our Lab Products and Services division’s offering of cell analysis instruments, reagents, and AI-supported data models. Our combined portfolio will be one of the most comprehensive solution offerings on the market, enabling researchers to speed up new therapy development and reduce animal testing.”

Geographical Insights

North America

North America dominated the single-use bioprocessing market in 2024. The dominance of this region is due to technological advancements in biomanufacturing and the pharmaceutical industry, with an increase in investment in research & development. The demand for single-use bioprocessing equipment has increased due to the requirement of such equipment for the production of vaccines to aid in disease prevention measures. The presence of the Bio Processing System Alliance (BPSA) in the North American region also plays a vital role in driving the market of the single-use bioprocessing market.

APAC

The Asia-Pacific region is projected to have rapid growth for the single-use bioprocessing market in the forecasted period of 2025-2034. The increase in the adoption of biotechnology in the healthcare sector drives the growth of the market. An increase in investment from global companies in the APAC region for the single-use bioprocessing market has resulted in the growth of research and development and overall sales.

China is one of the major contributors to the single-use bioprocessing market in the APAC region. The expansion of the pharmaceuticals market drives the growth of the single-use cell market throughout the nation. The primary focus of the nation is to develop affordable biosimilars of western novel biotherapeutics for its domestic market that will boost the market growth.

Europe

Europe is expected to grow in single-use bioprocessing in the forecasted period of 2025-2034. With the advancements in technology and investment by the government and private institutions in the single-use bioprocessing market, the region is rapidly growing.

Recent Developments

• In April 2025, Sartorius announced its agreement to acquire MatTek Corp, including Visikol Inc, from BICO Group AB.
• In June 2025, Diatech Pharmacogenetics announced an expansion of its collaboration with Merck Serono Middle East Ltd., affiliates of Merck KGaA ("Merck"). The collaboration aims to improve patient access to RAS biomarker testing in the Middle East and Africa (MEA). Colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases.
• In April 2024, Bio-Techne entered into a strategic distribution agreement with Thermo Fisher Scientific to provide cutting-edge solutions to its customers. These two industry leaders in the fields of research, biotechnology, and diagnostics under this agreement shall distribute Bio-Techne's extensive portfolio of products to the European market through Fisher Scientific’s channel.

Competitive Landscape

The single-use bioprocessing market is a highly competitive market with many leading players, including Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher, Avantor, Inc., and many more. The market is highly competitive with players that are focused on developing cutting-edge technology and are investing in research and development of bioprocessing equipment.

The market is dominated by several companies, but the companies that are renowned for their contribution in the market are listed below:

• Company Name: Thermo Fisher Scientific
• Year of Incorporation: 2006
• Headquarters: Waltham, Massachusetts

Thermo Fisher Scientific was established by a merger between Thermo Electron and Fisher Scientific. It provides many kinds of products and services throughout 600+ locations across America, APAC, and EMEA regions.

• Company Name: Merck KGaA
• Year of Incorporation: 1668
• Headquarters: Darmstadt, Germany

Merck achieved substantial growth, with an annual revenue of $ 64 billion in the year 2024, with a fair increase from the previous year, and is expected to grow at the same rate in the forecasted period.

• Company Name: Sartorius AG
• Year of Incorporation: 1870
• Headquarters: Göttingen, Germany

Sartorius AG provides a broad product portfolio it covers all the steps that are involved in the production of biopharmaceuticals. The company has grown rapidly and recorded a revenue of $312.08 billion in 2024.